Cargando…

Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience

INTRODUCTION: Triple-negative breast cancer (TNBC) lacks estrogen and progesterone receptors and does not overexpress HER2. It displays a distinct clinical behavior. This study aims to assess the clinical, molecular and prognostic characteristics of TNBC patients. PATIENTS/METHODS: TNBC patients, re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asleh-Aburaya, Karama, Fried, Georgeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372619/ https://www.ncbi.nlm.nih.gov/pubmed/25825688 http://dx.doi.org/10.1186/s40064-015-0900-3

Ejemplares similares

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022)

Advances in sarcoma diagnostics and treatment
por: Dancsok, Amanda R, et al.
Publicado: (2016)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience
por: Vetter, Marcus, et al.
Publicado: (2017)

Anaplastic Variant of Classical Seminoma of the Testis: Northern Israel Oncology Center Experience and Brief Review of Literature
por: Stein, Moshe E., et al.
Publicado: (2014)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Clinical Characteristics in Patients with Triple Negative Breast Cancer
por: Yeh, Janet, et al.
Publicado: (2017)

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
por: Fan, Yiqi, et al.
Publicado: (2022)

Clinicopathological characteristics of breast cancer patients from Northern Tanzania: common aspects of late stage presentation and triple negative breast cancer
por: Gnanamuttupulle, Marianne, et al.
Publicado: (2021)

Asymptomatic Visceral Leishmaniasis, Northern Israel
por: Adini, Irit, et al.
Publicado: (2003)

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
por: Asleh, Karama, et al.
Publicado: (2023)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
por: Cattaneo, Daniele, et al.
Publicado: (2021)

Ultrasound and Clinicopathological Characteristics of Triple Receptor-Negative Breast Cancers
por: Choi, Yoon Jung, et al.
Publicado: (2011)

Clinical significance of morphologic characteristics in triple negative breast cancer
por: Ryu, Dong Won, et al.
Publicado: (2011)

Ritual plants of Muslim graveyards in northern Israel
por: Dafni, Amots, et al.
Publicado: (2006)

Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
por: Sivina, Elina, et al.
Publicado: (2023)

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
por: Peddi, Parvin F., et al.
Publicado: (2012)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman, Michael L, et al.
Publicado: (2015)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Ibragimova, Marina K., et al.
Publicado: (2021)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
por: Ryu, Won-Ji, et al.
Publicado: (2021)

Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review
por: Yamaguchi, Junzo, et al.
Publicado: (2021)

Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel
por: Zaidenstein, Ronit, et al.
Publicado: (2008)

Operative Treatment of Hepatic Hydatid Cysts: A Single Center Experience in Israel, a Nonendemic Country
por: Maoz, Daniel, et al.
Publicado: (2013)

Inhabited rural centers in Israel /
Publicado: (1968)

Motor Vehicle Accident Eye Injuries in Northern Israel
por: Yulish, Michael, et al.
Publicado: (2014)

Genetics of hearing loss in the Arab population of Northern Israel
por: Danial-Farran, Nada, et al.
Publicado: (2018)

Uptake of pneumococcal vaccination in older people in northern Israel
por: Eilat-Tsanani, Sophia, et al.
Publicado: (2021)

Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments
por: Chen, Lulu, et al.
Publicado: (2023)

Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience
por: Kumar, Shiyam, et al.
Publicado: (2019)

CHARACTERISTICS AND PROGNOSIS OF TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A CROATIAN SINGLE INstitution RETROSPECTIVE COHORT STUDY
por: Tečić Vuger, Ana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l4mtlvrdc6tg5r3g7bb7oljb68